Free Trial

The Clorox Company (NYSE:CLX) Shares Sold by Bank of New York Mellon Corp

Clorox logo with Consumer Staples background

Bank of New York Mellon Corp reduced its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 12.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 815,903 shares of the company's stock after selling 116,502 shares during the period. Bank of New York Mellon Corp owned 0.66% of Clorox worth $132,511,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Brooklyn Investment Group raised its stake in Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after purchasing an additional 95 shares during the period. Prospera Private Wealth LLC purchased a new position in shares of Clorox in the 3rd quarter worth $27,000. Continuum Advisory LLC boosted its holdings in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company's stock valued at $30,000 after acquiring an additional 138 shares during the last quarter. Asset Planning Inc purchased a new stake in Clorox during the fourth quarter valued at about $32,000. Finally, BankPlus Trust Department acquired a new stake in Clorox during the fourth quarter worth about $40,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. TD Cowen raised Clorox from a "sell" rating to a "hold" rating and lifted their price objective for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Wells Fargo & Company increased their price objective on shares of Clorox from $157.00 to $161.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 4th. Barclays lifted their target price on shares of Clorox from $130.00 to $140.00 and gave the company an "underweight" rating in a report on Wednesday, February 5th. StockNews.com downgraded Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. Finally, DA Davidson reduced their price objective on Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 5th. Three equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the company. According to MarketBeat.com, Clorox currently has a consensus rating of "Hold" and a consensus price target of $159.62.

Read Our Latest Stock Report on Clorox

Clorox Stock Down 2.2 %

CLX traded down $3.41 during trading on Tuesday, hitting $152.48. The company had a trading volume of 1,208,447 shares, compared to its average volume of 1,377,399. The company has a market cap of $18.78 billion, a PE ratio of 41.63, a P/E/G ratio of 2.62 and a beta of 0.42. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The business has a 50-day moving average of $156.73 and a 200-day moving average of $160.44.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the previous year, the company earned $2.16 EPS. As a group, analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be issued a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.20%. The ex-dividend date is Wednesday, April 23rd. Clorox's dividend payout ratio (DPR) is presently 133.33%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

3 AI Stocks to Watch After NVIDIA’s Dip

3 AI Stocks to Watch After NVIDIA’s Dip

NVIDIA may be down, but the AI boom isn’t slowing anytime soon! While investors react to short-term price swings, smart money is looking at three stocks that could benefit from NVIDIA’s continued domi

Related Videos

5 Stocks to BUY NOW in March 2025
NVIDIA Revenue SOARS 78%, But Volatility Won’t STOP!
NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines